Guardant Health, Inc.GH
Market cap
$12.7B
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 7 | 11 | 16 | 22 | 36 | 43 | 42 |
| Stock-based compensation | 7 | 17 | 144 | 151 | 95 | 91 | 140 |
| Cash from operations | -72 | -47 | -104 | -209 | -309 | -325 | -240 |
| Capital expenditures | -20 | -19 | -36 | -75 | -77 | -20 | -35 |
| Cash from investing | -153 | -318 | -617 | -63 | 150 | 840 | -261 |
| Repurchases of common stock | 0 | - | - | - | - | - | - |
| Cash from financing | 293 | 367 | 1,410 | -67 | -189 | 477 | -1 |
| Free cash flow | |||||||
| FCF margin (%) |